BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20340055)

  • 41. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck.
    Hoffmann TK; Balló H; Braunstein S; Van Lierop A ; Wagenmann M; Bier H
    Oral Oncol; 2001 Jan; 37(1):50-6. PubMed ID: 11120483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Research on the relationship between serum levels of inflammatory cytokines and non-small cell lung cancer.
    Song XY; Zhou SJ; Xiao N; Li YS; Zhen DZ; Su CY; Liu ZD
    Asian Pac J Cancer Prev; 2013; 14(8):4765-8. PubMed ID: 24083740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy.
    Dietz A; Rudat V; Conradt C; Weidauer H; Ho A; Moehler T
    Head Neck; 2000 Oct; 22(7):666-73. PubMed ID: 11002321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck.
    Gehrmann M; Specht HM; Bayer C; Brandstetter M; Chizzali B; Duma M; Breuninger S; Hube K; Lehnerer S; van Phi V; Sage E; Schmid TE; Sedelmayr M; Schilling D; Sievert W; Stangl S; Multhoff G
    Radiat Oncol; 2014 Jun; 9():131. PubMed ID: 24912482
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
    Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
    BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new prognostic indicator for head and neck cancer--p53 serum antibodies?
    Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Werner JA
    Anticancer Res; 1999; 19(4A):2703-5. PubMed ID: 10470224
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of IL-18 in patients with head and neck squamous cell carcinoma.
    Riedel F; Adam S; Feick P; Haas S; Götte K; Hörmann K;
    Int J Mol Med; 2004 Feb; 13(2):267-72. PubMed ID: 14719133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma.
    Bongers V; Braakhuis BJ; Snow GB
    Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):479-82. PubMed ID: 8582085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum Level of Matrix Metalloproteinase-9 in Patients with Head and Neck Squamous Cell Carcinoma.
    Stanciu AE; Zamfir-Chiru-Anton A; Stanciu MM; Popescu CR; Gheorghe DC
    Clin Lab; 2016 Aug; 62(8):1569-1574. PubMed ID: 28164611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum vascular endothelial growth factor-A (VEGF-A) as a biomarker in squamous cell carcinoma of head and neck patients undergoing chemoradiotherapy.
    Srivastava VK; Gara RK; Rastogi N; Mishra DP; Ahmed MK; Gupta S; Goel MM; Bhatt ML
    Asian Pac J Cancer Prev; 2014; 15(7):3261-5. PubMed ID: 24815480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic impact of tumor IL-6 expression after preoperative chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
    Yoneda M; Fujiwara H; Furutani A; Ikai A; Tada H; Shiozaki A; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Konishi H; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Otsuji E
    Anticancer Res; 2013 Jun; 33(6):2699-705. PubMed ID: 23749929
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of interleukin-7 and interleukin-8 in head and neck squamous cell carcinoma.
    Mojtahedi Z; Khademi B; Erfani N; Taregh Y; Rafati Z; Malekzadeh M; Ghaderi A
    Indian J Cancer; 2014; 51(3):227-230. PubMed ID: 25494110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of serum alkaline DNase activity in treatment monitoring of head and neck cancer patients.
    Patel PS; Patel BP; Rawal RM; Raval GN; Patel MM; Patel JB; Jha FP; Patel DD
    Tumour Biol; 2000; 21(2):82-9. PubMed ID: 10686537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
    De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
    BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
    Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
    Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.
    Banerjee J; Pradhan R; Gupta A; Kumar R; Sahu V; Upadhyay AD; Chaterjee P; Dwivedi S; Dey S; Dey AB
    Clin Transl Oncol; 2017 May; 19(5):571-578. PubMed ID: 27815686
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The significance of Tenascin-C serum level as tumor marker in squamous cell carcinoma of the head and neck.
    Pauli C; Stieber P; Schmitt UM; Andratschke M; Hoffmann K; Wollenberg B
    Anticancer Res; 2002; 22(5):3093-7. PubMed ID: 12530049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
    Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
    BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sedimentation rate and serum thymidine kinase activity: prognostic factors in squamous cell head and neck cancer.
    Fontana X; Dassonville O; Néri J; Vallicioni J; Santini J; Milano G; Combon P; Lapalus F; Demard F
    Head Neck; 1993; 15(5):425-32. PubMed ID: 8407315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.